Author:
Shretta Rima,Ngwafor Anye Randolph
Abstract
Abstract
This article examines a policy of scaling up LLINs by 10 percentage points from 2020 levels with a 90% cap in the 29 highest-burden countries in Africa along with social and behavioral change (SBC) and information education and communication (IEC) campaigns to increase the use and effectiveness of LLINs. The incremental cost of this scenario compared to a baseline of maintaining malaria interventions at 2020 levels has a present-day (2023) value of 5.7 billion US$ 2021 discounted at 8% over the period 2023–2030 (undiscounted starting at US$ 416 million in 2023 increasing to US$ 1.4 billion in 2030). This investment will prevent 1.07 billion clinical cases and save 1,337,069 lives. With standardized Copenhagen Consensus Center assumptions, the mortality benefit translates to a present value of US$ 225.9 billion. The direct economic gain is also substantial: the incremental scenarios lead to US$ 7.7 billion in reduced health system expenditure from the reduced treatment of cases, a reduction in the cost of delivering malaria control activities, and reduced household out-of-pocket expenses for malaria treatment. The productivity gains from averted employee and caretaker absenteeism and presenteeism add benefits with a present value of US$ 41.7 billion. Each dollar spent on the incremental scenario delivers US$ 48 in Societal.
Funder
Bill and Melinda Gates Foundation
Publisher
Cambridge University Press (CUP)
Subject
Public Administration,Economics and Econometrics,Sociology and Political Science
Reference78 articles.
1. Effectiveness and Cost-Effectiveness Against Malaria of Three Types of Dual-Active-Ingredient Long-Lasting Insecticidal Nets (LLINS) Compared with Pyrethroid-Only LLINS in Tanzania: A Four-Arm, Cluster-Randomised Trial;Mosha;Lancet,2022
2. Modelling the Impact of Rapid Diagnostic Tests on Plasmodium Vivax Malaria in South Korea: A Cost-Benefit Analysis;Kim;BMJ Global Health,2021
3. Health Gains and Financial Risk Protection Afforded by Public Financing of Selected Malaria Interventions in Ethiopia: An Extended Cost-Effectiveness Analysis;Assebe;Malaria Journal,2020
4. Robinson, L.A. , Hammitt, J. K. , Cecchini, M. , Chalkidou, K. , Claxton, K. , Cropper, M. , Hoang-Vu Eozenou, P. , de Ferranti, D. , Deolalikar, A. B. , Guanais, F. , Jamison, D. T. , Kwon, S. , Lauer, J. A. , O’Keeffe, L. , Walker, D. , Whittington, D. , Wilkinson, T. , Wilson, D. , and Wong, B. . 2019. Reference Case Guidelines for Benefit-Cost Analysis in Global Health and Development, funded by the Bill & Melinda Gates Foundation. Available at https://ssrn.com/abstract=4015886.
5. Cost-Effectiveness of PBO versus Conventional Long-Lasting Insecticidal Bed Nets in Preventing Symptomatic Malaria in Nigeria: Results of a Pragmatic Randomized Trial;Shepard;American Journal of Tropical Medicine and Hygiene,2020